UltraSight secures $24 million in Series B2 funding for AI-guided cardiac ultrasound
UltraSight announced it has raised $24 million in a Series B2 funding round. The company states this capital will be used to expand its AI-guided cardiac ultrasound technology. This information is primarily based on the company's own announcement, as reported by both DOTmed and MassDevice.
2 articles from 2 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
2 outlets covered “UltraSight secures $24 million in Series B2 funding for AI-guided cardiac ultrasound”. All of them report the following:
- UltraSight raised $24 million
- Funding is for Series B2 round
- Funds will be used to scale AI-guided cardiac ultrasound technology
Which outlets covered this?
All 2 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.